Budapest nephrology school - 30 years of history - from modest start to an international success: systematic summary of the 27th BNS held between 28th August and 2nd of September 2023 [0.03%]
布达佩斯肾脏病学学校——三十年的历史——从简陋起步到国际成功：系统总结第27届BNS（2023年8月28日至9月2日举行）
Orsolya Cseprekál,Laszlo Rosivall
Orsolya Cseprekál
Budapest Nephrology School (BNS) could have celebrated its 30th event if it had not been interrupted by COVID pandemic for a few years. Yet, the organization of 27th BNS in August 2023 resumed its successful and traditional activities at Se...
Iguratimod prevents renal fibrosis in unilateral ureteral obstruction model mice by suppressing M2 macrophage infiltration and macrophage-myofibroblast transition [0.03%]
伊瓜拉替莫通过抑制M2型巨噬细胞浸润和巨噬细胞肌成纤维细胞转化防治单侧输尿管结扎小鼠肾纤维化
Yueyuan Zhou,Zhilan Li,Shenyi Yu et al.
Yueyuan Zhou et al.
Iguratimod is a novel synthetic, small-molecule immunosuppressive agent used to treat rheumatoid arthritis. Through ongoing exploration of its role and mechanisms of action, iguratimod has been observed to have antifibrotic effects in the l...
Assessing the role of Chemokine (C-C motif) ligand 14 in AKI: a European consensus meeting [0.03%]
欧洲共识会议评估趋化因子(C-C基序)配体14在急性肾损伤中的作用
Jay L Koyner,Christian Arndt,Jaume Baldira Martinez de Irujo et al.
Jay L Koyner et al.
Background: Urinary Chemokine (C-C motif) ligand 14 (CCL14) is a biomarker associated with persistent severe acute kidney injury (AKI). There is limited data to support the implementation of this AKI biomarker to guide th...
Factors associated with post-hospitalization dialysis dependence in ECMO patients who required continuous renal replacement therapy [0.03%]
接受持续性肾脏替代治疗的体外膜氧合患者的住院后透析依赖因素分析
Carlos Rodrigo Franco Palacios,Rudiona Hoxhaj,Catlyn Thigpen et al.
Carlos Rodrigo Franco Palacios et al.
Objective: This single center retrospective study aimed to describe the variables associated with outpatient dialysis dependence in extracorporeal membrane oxygenation (ECMO) patients who needed continuous renal replaceme...
Shenkang injection for the treatment of acute kidney injury: a systematic review and meta-analysis [0.03%]
升降散治疗急性肾损伤：系统评价和.meta.分析
Shengchun Liao,Yurou Chen,Shuting Wang et al.
Shengchun Liao et al.
Objective: Shenkang injection (SKI) has been widely used in China for many years for the treatment of kidney disease. The objective of this systematic review was to assess the efficacy of Shenkang injection for the treatm...
Meta-Analysis
Renal failure. 2024 Dec;46(1):2338566. DOI:10.1080/0886022X.2024.2338566 2024
Exploring alternatives to laparoscopic renal biopsy: a critical examination of safety, efficacy, and costs [0.03%]
腹腔镜肾活检替代方法的安全性、有效性和成本效益的批判性分析
David Fernando Torres Cortes,Daniela Carrascal,Gonzalo Andrés Montaño Rozo et al.
David Fernando Torres Cortes et al.
The prevalence of functional dyspepsia using Rome IV questionnaire among chronic kidney disease patients [0.03%]
罗马四问诊表在慢性肾病患者功能性消化不良中的应用及流行病学研究
Omar Abdelazim,Alshymaa A Hassnine,Basma Fathy et al.
Omar Abdelazim et al.
Background: Symptoms of dyspepsia are usually encountered by chronic kidney disease patients. Abdominal discomfort is commonly seen in CKD patients with no other causes of organic affection. Aim: to determine the prevalence of functional dy...
Observational Study
Renal failure. 2024 Dec;46(1):2344651. DOI:10.1080/0886022X.2024.2344651 2024
Rui Cheng,Liang Xu,Jianhua Gong et al.
Rui Cheng et al.
Previous studies have highlighted the significant role of complement activation in kidney injuries induced by rhabdomyolysis, intravascular hemolysis, sepsis, and ischemia-reperfusion. Nevertheless, the specific role and mechanism of comple...
Prognostic value of neutrophil-to-lymphocyte ratio dynamics in patients with septic acute kidney injury: a cohort study [0.03%]
中性粒细胞与淋巴细胞比值变化对脓毒症急性肾损伤患者预后的影响：队列研究
Wei Wei,Caihong Liu,Guojiao Song et al.
Wei Wei et al.
Background: Neutrophil-to-lymphocyte ratio (NLR) has been suggested to be a prognostic marker for various diseases, but whether NLR dynamics (ΔNLR) is related to mortality and disease severity in patients with septic acu...
Immunosuppressive treatment results in patients with primary IgA nephropathy in Turkiye; the data from TSN-GOLD working group [0.03%]
土耳其IgA肾病患者免疫抑制治疗结果；TSN-GOLD工作组数据
Aysegul Oruc,Abdullah Sumnu,Aydın Turkmen et al.
Aysegul Oruc et al.
Background: Immunoglobulin A (IgA) nephropathy (IgAN) treatment consists of maximal supportive care and, for high-risk individuals, immunosuppressive treatment (IST). There are conflicting results regarding IST. Therefore...